lecular and biological nature of endometrial cancer
PhD ceremony: Ms. R.A. de Jong, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Molecular and biological nature of endometrial cancer
Promotor(s): prof. H.W. Nijman, prof. H. Hollema, prof. I.P. Kema
Faculty: Medical Sciences
Endometrial carcinoma is a heterogeneous disease with several histological types and different biological behavior. The general prognosis for endometrial carcinoma is good, but in patients diagnosed with non-endometrioid subtypes such as serous carcinoma, clearcell carcinoma or carcinosarcomas, life-expectancy decreases dramatically. Especially in these patients, the development of new treatment modalities is warranted to improve prognosis.
Immunotherapy is an interesting new treatment option where it is generally recognized that the immune system has an important role in regulating cancer development and progression. The research presented in this thesis shows that the immune system has a significant role in endometrial carcinoma. However, several mechanisms facilitate cancer cells to escape from immune-mediated recognition and killing by the immune system. In-depth knowledge of escape mechanisms is essential to design an (effective) immunotherapy-based treatment modality. This thesis demonstrated that escape mechanisms are present in endometrial carcinoma and significantly influence prognosis. Using this knowledge, it may become feasible to predict which patients will benefit from immunotherapeutic strategies. In addition to the identification of new treatment modalities, we also aim for improvement of standard treatment modalities. Currently, patients with high-risk endometrial carcinoma are treated with surgery and adjuvant external beam radiotherapy. Radiotherapy is associated with short and long-term morbidity and should therefore merely be used in patients who will benefit most. Our research shows that gastrointestinal symptoms are reduced when patients with high-risk endometrial carcinoma and without lymph-node metastases after adequate surgical staging, are treated with external beam radiotherapy that is limited to a small pelvic field as compared to a standard pelvic field treatment.
Last modified: | 13 March 2020 01.02 a.m. |
More news
-
24 May 2024
Lustrum 410 in pictures
Lustrum 410 in pictures: We are already over half way through our lustrum! Enjoy a few photos of the lustrum so far.
-
21 May 2024
Results of 2024 University elections
The votes have been counted and the results of the University elections are in!
-
15 May 2024
Part of the children with ADHD can stop using Ritalin sooner
A part of children with ADHD could stop taking Ritalin after two years. This is the conclusion of Anne-Flore Matthijssen's PhD research.